Company / Return on Equity (ROE)
Doximity Return on Equity (ROE) History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
24.8%
FY2024
5-year range
12.8% / 231.9%
FY2020-FY2024
Trend
+62.0%
vs FY2023
Sector context
#12 of 147
Health Care
What the data says
Among 147 Health Care companies, Doximity is in the top 8% for return on equity (roe). Improved from 12.8% to 24.8% over the past 2 years.
Based on SEC 10-K filings.
24.8% in FY2024 with a 3-year CAGR of -207.2%. Top quartile in the Health Care sector.
Improved from 12.8% to 24.8% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -207.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 8% in Health CareTop 8% of 147This company 24.8% Sector average -3.1%
▼
+893.4% above sector average
Key checks
Key Insights
- In FY2024, return on equity (roe) increased 62.0% year-over-year.
- Currently 27.9pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 24.8% | +62.0% |
| FY2023 | 15.3% | +19.0% |
| FY2022 | 12.8% | -94.5% |
| FY2021 | 231.9% | -94.8% |
| FY2020 | 4419.9% | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026